Blue Water Life Science Advisors, LP Adaptive Biotechnologies Corp Transaction History
Blue Water Life Science Advisors, LP
- $103 Million
- Q3 2025
A detailed history of Blue Water Life Science Advisors, LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 2,145,145 shares of ADPT stock, worth $30.2 Million. This represents 31.1% of its overall portfolio holdings.
Number of Shares
2,145,145
Previous 2,145,145
-0.0%
Holding current value
$30.2 Million
Previous $25 Million
28.42%
% of portfolio
31.1%
Previous 19.78%
Shares
9 transactions
Others Institutions Holding ADPT
# of Institutions
289Shares Held
147MCall Options Held
23.5KPut Options Held
33.3K-
Viking Global Investors LP30MShares$423 Million1.27% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$164 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$159 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN5.97MShares$84.2 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.3.65MShares$51.5 Million0.59% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.01B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...